SCHEMBL499710

SCHEMBL499710

COC(=O)NCCCN(C(=O)CN(C)C(=O)OC(C)(C)C)c1cccc(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
RAB9A P51151 2/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MTNR1A P48039 2/20 0.39
MTNR1B P49286 2/20 0.39
NPC1 O15118 2/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
AHCY P23526 1/20 0.37
TMEM97 Q5BJF2 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
DRD2 P14416 5/20 0.36
LMNA P02545 1/20 0.35
PKM P14618 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4754228 0.95 ALDH1A1 (0.37) ALDH1A1RAB9AHTTSMN1; SMN2MTNR1A
SCHEMBL499688 0.84 ALDH1A1 (0.40) ALDH1A1RAB9AMTNR1AMTNR1BNPC1
SCHEMBL499183 0.80 ALDH1A1 (0.61) ALDH1A1RAB9AHTTSMN1; SMN2NPC1
SCHEMBL10254268 0.80 ALDH1A1 (0.40) ALDH1A1RAB9AHTTSMN1; SMN2NPC1
SCHEMBL499259 0.79 ALDH1A1 (0.46) ALDH1A1RAB9AHTTSMN1; SMN2MTNR1A
SCHEMBL9525464 0.73 ALDH1A1 (0.43) ALDH1A1RAB9AHTTSMN1; SMN2NPC1
SCHEMBL30797543 0.73 ALDH1A1 (0.43) ALDH1A1RAB9AHTTSMN1; SMN2NPC1
SCHEMBL26599038 0.72 SUV39H2 (0.49) ALDH1A1MTNR1AMTNR1BNPC1GAA
SCHEMBL4753581 0.72 TMEM97 (0.45) ALDH1A1RAB9AMTNR1AMTNR1BNPC1
SCHEMBL8426236 0.72 KDM4E (0.41) ALDH1A1RAB9AHTTSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106221-B2 Renin inhibitors VITAE PHARMACEUTICALS, INC. (US) 2012-01-31 US disclosed
US-8106221-B2 Renin inhibitors VITAE PHARMACEUTICALS, INC. (US) 2012-01-31 US disclosed
US-20100144825-A1 Renin Inhibitors VITAE PHARMACEUTICALS, INC. 2010-06-10 US disclosed
US-20100144825-A1 Renin Inhibitors VITAE PHARMACEUTICALS, INC. 2010-06-10 US disclosed
WO-2008156816-A2 RENIN INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2008-12-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144825-A1 Renin Inhibitors ACE, REN, DNPEP ALDH1A1 1991/4885RAB9A 828/4885HTT 1270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.